Ente Ospedaliero Cantonale, Bellinzona

This study compares two approaches for people with relapsing multiple sclerosis who have been on anti-CD20 medications. It examines whether switching to a different drug called cladribine might help reduce infection risks while still controlling MS symptoms. The research follows …